Key result
The Coordinated Care in Myocardial Infarction Program (KOS-MI) reduced all-cause mortality by 40% (HR 0.60) compared to standard care at 3-year follow-up in patients after myocardial infarction.
Why the study?
The Coordinated Care in Myocardial Infarction Program was introduced to improve prognosis after MI, but its impact on 3-year major adverse cardiac and cerebrovascular events needed evaluation.
Does the Coordinated Care in Myocardial Infarction Program (KOS-MI) reduce mortality and major adverse cardiovascular events in patients after myocardial infarction compared to standard care?
Observational (n=1,972)
Yes
Does the Coordinated Care in Myocardial Infarction Program (KOS-MI) reduce mortality and major adverse cardiovascular events in patients after myocardial infarction compared to standard care?
A comprehensive coordinated care program following myocardial infarction significantly improves long-term survival and reduces major adverse cardiovascular events compared to standard care.
Answers are grounded in this paper and cite their sources.
KOS-MI participation was associated with lower 3-year MACCE after matching; leaves open whether coordinated post-MI programs improve outcomes in randomized settings.
BACKGROUND: The Coordinated Care in Myocardial Infarction Program (KOS-MI) was introduced to improve prognosis for patients after myocardial infarction (MI). The program includes complete revascularization followed by unrestricted access to rehabilitation, electrotherapy, and cardiac care. AIM: This study aimed to assess major adverse cardiac and cerebrovascular events (MACCE) of patients enrolled in the KOS-MI at 3-year follow-up. METHODS: This is a retrospective, multicenter registry of patients treated for MI. The study group (KOS-MI) of 963 patients was compared to the control group (standard care) of 1009 patients. At 3-year follow-up, MACCE including death, MI, stroke, and repeated revascularization were reported. Additionally, hospitalization for heart failure (HF) was analyzed. Propensity score matching (PSM) was utilized for group baseline characteristic adjustment. RESULTS: Patients in the KOS-MI group were younger (65 vs. 68 years; P <0.001), mostly men (70% vs. 62.9%; P <0.001), admitted with ST-segment elevation myocardial infarction (STEMI) (44.6% vs. 36.2%; P <0.001). Patients in the control group had more comorbidities and were admitted more often with non-ST-segment elevation myocardial infarction (63.8% vs. 55.4%; P <0.001) and acute HF (5.1% vs. 2.7%; P = 0.007). Following PSM, 530 well matched pairs were selected. At three years (92.3% follow-up completeness), the relative risk reduction was: 25% in MACCE (P = 0.008), 38% in mortality (P = 0.008), 29% in repeated revascularization (P = 0.04), and 28% (P = 0.0496) in hospitalization for HF in the KOS-MI group. CONCLUSIONS: The combination of contemporary invasive techniques, complete revascularization, cardiac rehabilitation, and ambulatory care included in the KOS-MI Program improves long-term prognosis of patients after MI in 3-year follow-up.
No takes yet. Share an insight, caveat, or question.
Kolarczyk‐Haczyk et al. (2023) conducted an observational in Myocardial Infarction (n=1,972). Coordinated Care in Myocardial Infarction Program (KOS-MI) vs. Standard care was evaluated on All-cause mortality (HR 0.60, 95% CI 0.41-0.87, p=0.008). The Coordinated Care in Myocardial Infarction Program (KOS-MI) reduced all-cause mortality by 40% (HR 0.60) compared to standard care at 3-year follow-up in patients after myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: